NCT04545346

Brief Summary

The study is investigating if following the low glutamate diet for 1 month, as compared to care as usual, can improve seizure frequency, severity, and duration; cognitive functioning; and/or quality of life in children with epilepsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2020

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 11, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

October 15, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

1.7 years

First QC Date

August 26, 2020

Last Update Submit

July 18, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in seizure frequency

    All families will keep a seizure diary recording the number of daily seizures. This will be used to accurately determine these variables for the last week, which will be recorded on seizure assessment forms.

    At 1 month post treatment

  • Change in seizure severity

    . During the last week of each study period, families will be asked to complete a seizure assessment form. This will include a subjective rating scale for seizure severity with a minimum score of 0 (not severe) and a maximum score of 10 (very severe).

    At 1 month post treatment

  • Change in seizure duration

    All families will keep a seizure diary recording the duration of seizures. This will be used to accurately determine these variables for the last week, which will be recorded on seizure assessment forms.

    At 1 month post treatment

Secondary Outcomes (3)

  • The effect of a 1-month low-glutamate diet on quality of life in children with epilepsy.

    At 1 month post treatment

  • The effect of a 1-month low-glutamate diet on cognitive functioning in children with epilepsy.

    At 1 month post treatment

  • Examine change in resting state brain waves after 1-month on the low glutamate diet

    At 1 month post treatment

Study Arms (2)

Wait-listed control

NO INTERVENTION

Participants continue care as usual. All all medications must be kept constant during the study period, unless medically necessary.

Low Glutamate diet

EXPERIMENTAL

Participants are put on the low glutamate diet for one month. The low glutamate diet reduces the consumption of free glutamate, while optimizing dietary micronutrient and antioxidant intake.

Other: Low Glutamate diet

Interventions

Participants will be given extensive online dietary training and assigned to follow the low glutamate diet for one month. The low glutamate diet reduces the consumption of free glutamate, while optimizing dietary micronutrient and antioxidant intake.

Low Glutamate diet

Eligibility Criteria

Age2 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • or more seizures per month
  • Willing to keep all medications constant during the study.
  • All medications have remained constant for 30 days prior to study enrollment
  • Any previously attempted dietary therapies stopped before study enrollment

You may not qualify if:

  • Known or suspected inborn errors of metabolism
  • Non-English speaking households

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

American University

Washington D.C., District of Columbia, 20016, United States

Location

Related Publications (1)

  • Sarlo GL, Kao A, Holton KF. Investigation of the low glutamate diet as an adjunct treatment for pediatric epilepsy: A pilot randomized controlled trial. Seizure. 2023 Mar;106:138-147. doi: 10.1016/j.seizure.2023.02.013. Epub 2023 Feb 20.

MeSH Terms

Conditions

Drug Resistant Epilepsy

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Kathleen Holton, MPH, PhD

    American University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 26, 2020

First Posted

September 11, 2020

Study Start

October 15, 2020

Primary Completion

June 15, 2022

Study Completion

June 15, 2022

Last Updated

July 20, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations